reduction in recruitment timelines 1 , 2. increased trial retention rates 3 , 4. increased patient interest 4. patients recruited from communities of color 1 , 4. of study team members believe data quality can be higher 5.

PPD is dedicated to creating environmental innovations to better predict, measure and identify strategies to reduce the greenhouse gas emissions on clinical trials. We are partnering with stakeholders across the clinical trial spectrum to better understand how we can digitize, decentralize and modernize clinical research to make it more environmentally friendly.

Learn more about how we are creating a healthy planet to support healthy patients. Foster a sustainable future in clinical trials through decentralized trial models. Read this Thermo Fisher interview — Making clinical trials more sustainable by digitization and decentralization. The PPD Decentralized Clinical Trial Sites Survey offers a look into a shifting and expanding market, allowing us to see where DCTs are headed and better understand site needs.

We surveyed high-level clinical trial site staff to provide invaluable industry insights. As the adoption of DCTs increases, it is essential to anticipate market needs, challenges and impacts. In , after pandemic-fueled growth in decentralized clinical trials, PPD mined industry opinions on the likely future composition of clinical trial operations.

The analysis aimed to determine how hybrid and fully decentralized models will be used alongside traditional constructs in efforts to increase efficiency, improve outcomes, and speed the progress of life-saving therapeutics. Access the data and insights on how the industry is pivoting to tackle clinical trials during the pandemic and beyond.

Even though cultural factors currently impact the acceptance rate of decentralized clinical trial DCT models in the Asia-Pacific APAC region, most countries in the APAC region are at the forefront of advanced technologies, and future widespread adoption of DCTs is anticipated.

Learn about how the current landscape of DCTs in the APAC region and how PPD can support future trials. Technology planning is a priority for the coming year. Paul Evans: Expecting an era of realism for DCTs. Efforts have largely focused on approaches that make sense for the back office of the sponsor or CRO.

This is not the case. Many patients appreciate and benefit from the option of in-person meeting with specialists in their disease area.

In addition to physical site visits, protocols should offer remote options for those who cannot or do not wish to come to the site.

Either way, diversity, equity, and inclusion will continue to be an important area of focus, with pressure ratcheting up for more improvements.

As is typical for our industry, this will involve evolution, not revolution. Clarity is needed in this area. On the question of whether pharmaceutical companies and CROs might support site outreach in underserved areas, Evans believes that this building of community relationships by sites is one of the costs of doing business.

By focusing solely on clinical research, these investors may be able to bring about much-needed change. Edited by Jill Dawson and Gary Cramer. From new clinical research professionals just starting out to industry veterans looking for ways to move ahead in their careers, ACRP is where success starts — and grows.

For organizations who want to provide their clinical study teams with continuous, ongoing education and professional development resources, Organization Membership is a turnkey and scalable solution.

Organization Membership. Good Clinical Practice GCP Simulation. Understanding Clinical Trial Protocols. Building Quality Management Systems.

Site Quality Management Tools. ACRP is committed to supporting clinical research professionals as they navigate adoption of decentralized clinical trials DCTs. This new resource center is designed to provide a foundational understanding of DCTs, community perspectives, and practical tools to help you along your journey.

Learn More. ACRP honors the Certification Milestone Achievers, an exclusive group of nearly 1, professionals who have consistently proven their commitment to conducting clinical trials safely, ethically, and to the highest standard.

ACRP Certified professionals say their achievement results in increased job responsibility, more employment and advancement opportunities, and recognition—including promotions, bonuses, and salary increases. Interested in a career in clinical research?

Explore career options, resources, and more to help you find your first opportunity in clinical research. Read December Issue.

This new white paper examines recent work by ACRP and its members to build awareness of the need for a new budget model for sites and to leverage the adoption of DCT elements to improve how sites are supported in their critical contribution to drug development.

Intro to In Vitro Diagnostics IVD : How We Can Come Together Globally to Work More Efficiently. Your ability to recruit patients - to identify the most qualified patients, to make enrollment as simple and seamless as possible, and to provide support from application to randomization - is the major determinant to whether or not you will be able run your trial on schedule and without running over budget.

This, of course, significantly impacts the time that it takes to bring new medicines into the hands of patients that need them. It is important to accurately estimate how great of a challenge patient recruitment is likely to be for your unique trial, and to develop strategies for success in this area early on when designing the trial.

At Clara Health, we built our platform to specialize in the patient recruitment of rare and sensitive patient populations. This scale is supplemented by partnerships with patient advocacy groups and our own in-house patient advocacy group, the Breakthrough Crew.

They have built a unique platform that helps to target, recruit, screen and refer patients for clinical trials. The company works to help with patient recruitment for clinical trials in all phases, as well as for medical device trials. Some features that AutoCruitment offers include risk-based pricing, and a 3-day startup time.

Clariness offers over 15 years of experience in patient recruitment and engagement. It is available in more than 50 countries, with top patient visitors coming from countries including Poland, Colombia, Great Britain, Germany, Brazil, Hungary, US, the Czech Republic and Ukraine.

Antidote is a clinical trial patient recruitment company that works with more than health non-profit organizations and patient advocates to connect patients to clinical studies.

Some of its offerings include targeted outreach through its network of partners and patient advocacy groups, lab-validated referrals, and clinical trial site support.

BBK Worldwide has over 35 years of experience in patient recruitment for clinical trials. In addition, this company offers a Patient Experience Management System branded as TrialCentralNet® or TCN® , which assists sponsors with the management, enrollment and engagement of patients throughout their entire clinical trial experience.

It is a free to use database, and more than , individuals have enrolled to receive notifications over the last 12 years that the company has been in business. Some of its offerings include study listings search feature for patients, digital omni-channel advertising of premium listings for sponsors, and web development for study landing page optimization.

ClinicalConnection supports clinical studies both in the U. and internationally. Worldwide Clinical Trials has been in the business of patient recruitment and clinical trials management for over 30 years, and has managed trials in more than 60 countries, with a focus on improving the patient experience.

While patient recruitment is only one of its services, the company specializes in managing early and late-stage research services that include protein binding and pharmacoeconomic modeling for pharmaceutical and biotechnology companies. Clinical Site Services CCSi works with study sponsors and CROs to develop and implement patient recruitment and enrollment solutions.

This company has a niche focus on patient recruitment, which also includes patient retention. Some of its service offerings include patient recruitment and engagement through digital and traditional media placements, site support, as well as software to track patients as they move through the recruitment funnel.

Based out of Miami, Florida, Biorasi has been in the business of clinical trials since , with a focus on patient recruitment and trial optimization. The therapeutic areas that the company tailors its solutions for include: rare diseases, neurology, nephrology, oncology, regenerative medicine, dermatology and digital therapeutics.

Some of its main service offerings include patient recruitment, decentralized clinical trials, COVID trials, and program optimization. Elligo Health Research primarily focuses on patient recruitment as its core service offering.

The company assists in randomizing patients for traditional, hybrid and decentralized clinical trials. Elligo Health Research has partnerships with over community-based healthcare practices, which enables the company to bring clinical trial opportunities to around million patients. Curavit Clinical Research offers a digital site solution for sponsors looking to conduct decentralized trials.

The company is able to provide patient recruitment services, as well as design and management of the study on its platform which supports remote monitoring. PatientEvolution has created several proprietary technologies and services in order to help researchers recruit qualifying patients to participate in clinical trials.

Some of these solutions include PatientCircuit, PatientVisibility, PatientBlast, and PatientDial. In addition, PatientEvolution also develops a range of educational resources, which are used by the clinical team to help patients learn about what to expect from the study, which improves patient compliance.

Clintec an IQVIA company is a global company that provides functional service support to sponsors and CROs in conducting clinical research. The company has been in business for 22 years and has offices in 49 countries. Clintec services many major therapeutic disciplines, including oncology, rare diseases, autoimmune diseases, and diabetes.

The solutions that the company offers are custom and depend on the nature of the clinical trial. Veristat is a global CRO with more than 26 years of experience in clinical trial planning and execution. The company has a wide range of service offerings, which also include patient recruitment.

Some other services include full service support, strategic and regulatory consulting, project management, and medical writing. Praxis is an agency that is niched in patient recruitment for clinical trials. The company brings to table over 18 years of experience, and uses multiple digital and offline channels to recruit patients.

Some additional services that the company offers include project management, protocol feasibility, and site relations management. In addition, Praxis also offers an in-house clinical trial data management tool PraxisDirect®, that offers sponsors and sites insights into enrollment date, performance and other metrics related to recruitment.

MMG is a global and full-service health communications company that specializes in patient recruitment and patient retention. Some of its service offerings include: patient recruitment and engagement strategy design and program optimization.

Founded in , Science37 specializes in virtual also known as decentralized clinical trials. The company has built a platform to host and conduct virtual clinical trials. Science37 acts as a digital site with the capability to monitor and engage patients without needing to travel to a physical site, which has potential benefits for accelerating recruitment timelines and increasing the diversity of patients.

StudyKik is a full-service patient recruitment agency that engages, recruits, enrolls and retains patients. The company has been operating since , and leverages the use of technology and social media to reach its patients.

Within the last 7 years, StudyKik has reached over 6 million patients and connected over 3. Some of its service offerings include: free-to-use study search platform, patient recruitment strategy consulting and implementation, as well as customized app technologies.

Acurian has over two decades of experience within the clinical trial recruitment industry. Its service offerings focus entirely on patient recruitment, and include patient engagement and patient retention.

The company offers three levels of study support which include 1 optimized enrollment, 2 site services solution with optimized enrollment, and 3 combined enrollment, site services solution, and core CRO services.

Founded in , TrialSpark is a healthcare technology company that accelerates patient recruitment. TrialSpark believes that the current approach that most sponsors and CROs use to run trials is inefficient and lacks effectiveness. This company utilizes both digital and traditional recruitment approaches, and the entire process is tied together with the human touch of its patient-focused study teams that engage doctors, sponsors and patients.

ThreeWire is an international patient recruitment agency with offices in Minneapolis and Frankfurt, Germany. The company works with pharmaceutical, biotech and medical device industries to provide sponsors and CROs patient recruitment, enrollment and retention services through direct-to-patient marketing.

ThreeWire features a variety of case studies on its website that showcase the processes they use for recruiting patients for clinical trials. Based in Melbourne, Australia, Trialfacts has been in the business recruiting patients for clinical trials since When working with sponsors and CROs, Trialfacts completes an analysis of the study protocol and target patient population to determine the number of patients that can be recruited, and makes a percent patient recruitment guarantee.

The company shares a detailed step-by-step process for how they typically recruit patients for studies on their website. This is one of the first questions to ask, and is fundamental to gauging whether the financial goals and incentive structures of the vendor align with what you would like to achieve, in terms of meeting timelines and hitting the minimum number of patients required for the trial to run.

This performance fee arrangement may incentivize the vendor to refer as many leads as possible, without properly qualifying the applicants. This arrangement can lead to sites slowing down and becoming overwhelmed, which increases the amount of time it takes for them to respond to patient applications.

Clara Health: Our approach to aligning financial interests is based on success metrics, which helps to ensure a mutually beneficial partnership. Therefore, we never charge on top-of-funnel metrics - such as number of clicks, website visits, or completed applications - that most often will not amount to any real results that you want to see.

Instead, we bear some of the financial risk, and collect success fees on factors such as patients who complete phone screening, visit study sites for final screening, and randomize into the trial.

With this alignment, we do not win unless you do, and it incentivizes our team to explore absolutely every option, from every recruitment angle, to ensure that we deliver only the results that actually matter to you and your team.

We understand that defining key performance metrics can be a lengthy and difficult process, in and of itself. When on the hunt for the right patient recruitment partner, it is important to find a team that can understand where you are at the moment, the challenges that your team is currently confronting, and the initiatives your team already has in the works.

Ultimately, the ideal partner must have the experience, the team capacity, and the technology to quickly understand the good - and the bad - of your current efforts, and augment it with their resources and capabilities.

Some of these augmentations may be their proprietary technologies, more expansive marketing strategies and reach, and authentic relationships with patient organizations in your therapeutic area.

Ideally you are looking to find a partner that can do the following four things:. Patient recruitment for clinical trials has significantly changed within the last decade; this trend has only accelerated during the COVID pandemic.

Others go to the other end of the spectrum and rely completely on digital recruitment strategies to enroll patients. Therefore, the ideal partner for any trial is the one that can quickly identify all the areas where your team is missing out on reaching potential patients, and have the capabilities to create and execute on an action plan.

The team likely has the infrastructure in place to be able to address a diverse set of recruitment challenges through a responsible, organized and data-driven approach. Clara Health: Our approach to clinical trial recruitment builds on strategies that work to drive results that matter, as quickly as possible.

Clara Health augments traditional recruitment with stellar digital and patient advocacy-driven recruitment, giving your trial the absolute best shot to meet your recruitment timelines and the required number of patients.

And because of our diverse in-house capabilities, we can generate the content, marketing materials, and partnerships that are necessary to take a plan from paper into production.

This modern, ultra-targeted omni-channel marketing approach allows us to successfully help sponsors recruit for some of the most challenging rare disease clinical trials, making it possible to consistently deliver exceptional results for our current and past partners.

It is quite important to understand what the communication expectations are, because you will be working with the partner of your choice for the duration of the recruitment phase of your trial.

Below we have included questions pertaining to the communication structure and reporting that we recommend you get clarification on prior to signing with a vendor:. In general, what you are looking for in a patient recruitment vendor is a team that is consultative and is quick to respond to change, as things may be changing quite rapidly when everything is up and running.

The need for this is especially visible during COVID, as there are unpredictable situations such as study sites shutting down with no notice, while patients are on-hold and need to be frequently engaged. The ideal recruitment partner will be able to look at how things are going at the moment and with a consultative approach be able to tell you exactly what may happen next, along with all the possible solutions to these potential challenges.

In addition, this partner must have the capacity to quickly put these plans into action, and constantly keep you in the loop as events unfold. It is recommended that you determine what communication requirements you have, and match them against what the vendor is able to provide until finding the ideal partner.

Doing this will ensure that your needs are met consistently throughout the entire process, ultimately giving you the best chance of success with your trial. Clara Health: At Clara Health, we assign a designated project manager that is going to be the best link between our partners, study sites, and our internal team that will be facilitating the execution of recruitment and patient support services.

This unique placement allows us to have the most complete, accurate, and up-to-date information regarding the recruitment process, which we relay back to our partners during weekly meetings.

For example, we may receive feedback from several patients that they are not happy with a particular study site. We are able to collect and analyse this data, and share what we find back to our partners.

In another scenario, if a number of sites are burdened by similar logistical issues, our team is able to group the feedback together for resolution by the sponsor.

In addition, our partners are provided with access to an online dashboard where they can see all relevant metrics regarding our progress with recruiting patients throughout the duration of the study. This blend of high-touch support for patients and study site teams, dedicated project management for sponsors, and real-time data reporting provide Clara partners a command center for their recruitment operations.

Depending on if you are looking for patient recruitment help in the beginning of the trial, or if you are having a difficult time with recruitment later on, it makes a difference which patient recruitment agency is best to contract for your trial.

Some vendors specialize in optimizing study design for patient recruitment, which would involve more early stage consulting on protocol design. We advise you to ask the recruitment agency under consideration what kind of experience and success stories they can share with you for the specific type of help that you require.

Clara Health: For each of our clients, we assign a unique study team that is able to support them in both early and late stages of recruitment. A significant benefit of working with us from the beginning of the design process, is that we are able to play a centralized role and offload a lot of work from your study sites and your internal sponsor team, by consolidating a lot of the patient-facing activities through one central resource.

We are able to coordinate with the travel vendor to make sure that the patient never sees an interruption throughout their trial experience.

Our unique position right in the middle of the communications between your external vendors, the study sites and your team allows us to make sure that the patients have a seamless, and fully integrated experience.

In another scenario, your study sites may have a list of potential patients, but may not have the resources to adequately screen the patients. In this case, they can send these lists to be processed by our patient support team, which will increase the speed and quality of recruitment, as well as improve the patient experience.

If you're a healthy person, being in a clinical trial might help people who are not as healthy as you and might provide you with a unique experience – one in Exclusive Clinical Trials. Access to exclusive trials tailored to research interests and patients' needs through EHR data. Study Pipeline and Placement. Study Velocity Clinical Research is always seeking participants for clinical trials of medications, vaccines, medical devices, and more

Exclusive trial opportunities - Why should I join a clinical trial? Gain exclusive access to new, emerging treatments; Potentially improve your symptoms; Contribute to science and the If you're a healthy person, being in a clinical trial might help people who are not as healthy as you and might provide you with a unique experience – one in Exclusive Clinical Trials. Access to exclusive trials tailored to research interests and patients' needs through EHR data. Study Pipeline and Placement. Study Velocity Clinical Research is always seeking participants for clinical trials of medications, vaccines, medical devices, and more

However, many sponsors, including large pharmaceutical and biotechnology companies, are already opting to maintain direct relationships with sites during the trial process. Sponsors can further engage sites in the trial design process by providing them with the draft protocol and addressing any specific questions or concerns in a review call.

Utilize that expertise—they have so much knowledge to offer. A significant portion of the technology utilized at sites aims to enhance efficiency, ensure regulatory adherence, and mitigate risks. This encompasses tools such as electronic medical records for patient records, a clinical trial management system for trial scheduling and patient visits, and others.

Sites display remarkable resourcefulness, often devising a workflow solution by amalgamating various commercial solutions, spreadsheets, and in-house tech innovations.

The absence of these systems can hinder sites from expanding and conducting multiple trials while effectively managing risk and compliance. A prevalent challenge arises from the fact that technological solutions are frequently developed and chosen primarily with sponsor needs in mind, without consideration to site workflows or experience.

This leads to sites grappling with a surplus of tools without streamlined solutions for facilitating their day-to-day operations. On an average basis, sites use around 12 distinct technological components in each trial. Considering many sites oversee multiple simultaneous trials, the burden becomes clearly evident.

Inquiries should focus on the integration and data exchange capabilities of new solutions with existing site tools. User experience is equally vital; assessing how platforms are perceived by sites and patients and engaging sites for feedback during the review process are crucial considerations.

Opting for site-centric technology can bring benefits for all stakeholders—from sites and sponsors to CROs and vendors.

Such technology alignment reduces the need for redundant data input, thereby reducing the risk of errors and duplicative effort by site staff. Additionally, it brings about insights from data more quickly by eliminating the need to enter results into multiple systems, often well after patient visits.

While it is important to recognize the value of platforms spanning the entirety of a trial, there remains room for enhancing the overall workflow. Currently, workflows and systems are often compartmentalized and centered around specific trial aspects or processes.

This raises the question of whether we are potentially overlooking opportunities to leverage data and solutions from one phase of the trial to inform and enhance downstream processes. Such an approach would clash with the diverse and intricate requirements of various trials.

Currently, platforms are emerging for establishing vertical connections that link sites, sponsors, CROs, and vendors. These solutions are adaptable across a broader range of trials and are seamlessly integrated into site workflows. Sponsors, as the financial backers of trials, wield the necessary influence to implement these changes.

By viewing the trial workflow as an interconnected ecosystem rather than isolated components, we can quickly identify areas for improvement that need a champion to lead the charge. The essential components are already there—they simply need to be put together.

In an increasingly complex and competitive clinical trial landscape, it is crucial that sponsors rethink the role of sites. By involving site representatives early in the trial design process, sponsors can tap into their wealth of experience and insights, ensuring that protocols are not only patient-centric but also operationally feasible.

Prioritizing site-centric technologies is another crucial aspect, as it empowers sites to manage multiple trials efficiently, reducing redundancies and the risk of errors. The synergy between sponsor-selected technology and site workflows paves the way for a smoother, more integrated trial ecosystem.

Moreover, by embracing universal processes that foster interconnectedness across all stages of a trial, sponsors can lead the charge in driving comprehensive and impactful change.

As the driving force behind clinical trials, sponsors have the unique opportunity to reshape the industry by aligning incentives, fostering collaboration, and placing sites at the heart of trial innovation. Through these strategic initiatives, sponsors can emerge as innovators in clinical trial execution, setting a new standard of excellence in a competitive and evolving landscape.

Matt Smith is Vice President of Site Development for Slope. From new clinical research professionals just starting out to industry veterans looking for ways to move ahead in their careers, ACRP is where success starts — and grows.

For organizations who want to provide their clinical study teams with continuous, ongoing education and professional development resources, Organization Membership is a turnkey and scalable solution.

Organization Membership. Good Clinical Practice GCP Simulation. Understanding Clinical Trial Protocols. Building Quality Management Systems. Site Quality Management Tools. ACRP is committed to supporting clinical research professionals as they navigate adoption of decentralized clinical trials DCTs.

This new resource center is designed to provide a foundational understanding of DCTs, community perspectives, and practical tools to help you along your journey. Learn More. ACRP honors the Certification Milestone Achievers, an exclusive group of nearly 1, professionals who have consistently proven their commitment to conducting clinical trials safely, ethically, and to the highest standard.

ACRP Certified professionals say their achievement results in increased job responsibility, more employment and advancement opportunities, and recognition—including promotions, bonuses, and salary increases. Interested in a career in clinical research?

The conference will focus on advancing and implementing innovative solutions for all aspects of clinical trial planning, management, and operations.

SCOPE saw over 2, leaders in clinical operations and research attend, and all conference tracks will feature best practice case studies relevant to experts in clinical operations as well as newcomers to the field. Patients as Partners USA. March 20 — 22, Washington, DC.

The event also includes a guided session focused on co-creating solutions to typical barriers that patients face when participating in a clinical trial, and a chance to meet with patients directly to gain their perspectives on clinical trial experiences, challenges, and opportunities for improvement.

With the development of decentralized clinical trials, ensuring clinical quality is becoming more challenging. The event will equip you with practical tools and best practices to apply risk management methodologies throughout the clinical research lifecycle, while keeping up with emerging trends and innovations in the field.

AMIA Annual Symposium. November , New Orleans, LA. The AMIA Annual Symposium will focus on cutting edge research around five main areas: translational bioinformatics, clinical research informatics, clinical informatics, consumer health informatics, and public health informatics.

Attendees can expect to learn about the latest developments in areas such as data privacy, clinical decision support tools, phenotyping, and natural language processing. The conference welcomes students, educators, and researchers from academia as well as the industry who will all benefit from learning about the newest informatics developments.

FDA Clinical Trial Requirements Regulations, Compliance and GCP Conference. March , Palm Springs, CA. This two-day conference is intended to share information among FDA representatives and the regulatory community. The program will focus on the relationships among the FDA and clinical trial staff, investigators, and IRBs.

Participants will work through three areas that present challenges to sponsors and investigational sites: FDA clinical research requirements, enhancing success through communication and financial incentives, and assuring confidence in clinical research.

April May 1, Dallas, TX. The instalment brings the clinical research community together to learn the practical strategies, best practices, and creative solutions needed to ensure quality and integrity in the clinical research process.

MAGI's Clinical Research Conference May , Philadelphia, PA - East. October , San Francisco, CA - West. At the last MAGI conference, participants gathered an average of 10 practical tips to implement in their own organizations! Over people including representatives from over sponsors and CROs will attend more than 45 sessions offering practical intelligence they can put to use in their work right away.

May , Baltimore, MD. The 44th Annual Meeting of the Society for Clinical Trials will bring experts from academia, the pharmaceutical and device industries, government agencies, medical groups and clinical research entities together.

DIA Global Annual Meeting. June , Boston, MA. The DIA Global Annual Meeting will cover timely and practical topics catered to clinical trial scientists and statisticians who develop new drugs and biologics. The unique open discussion forum brings together voices from the industry, academia, patient advocacy, and regulatory agencies who will have the chance to engage in dialogue with one another.

Watch and join in as the audience collaboratively explores real world applications of innovative approaches and solutions for statistical challenges surrounding the design and analysis of clinical trials. Biotech Week Boston.

September , Boston, MA. Biotech Week Boston is dedicated to accelerating the business of biotechnology through new ideas, science, technology, and partnerships to make a positive impact on patient health. Outsourcing in Clinical Trials Series March , San Francisco, CA.

May , Barcelona, Spain. May , Burlingame, CA. May , King of Prussia, PA. OCT brings an intellectually driven, two-day program which will include numerous panels, debates, interviews and case-study presentations.

Hear from the leading voices in clinical outsourcing who are best situated to answer your questions and provide you the insight you need to maximize your budget and get drugs to patients. The 3-day conference will address the most critical billing and compliance challenges in clinical trials.

The event is a must-attend for professionals from hospitals, university medical centers, CROs and other clinical service providers involved in clinical research billing. Decentralized Clinical Trials Summit.

October exact date TBC Philadelphia, PA. The Decentralized Clinical Trials Summit, hosted by the Fierce Clinical Collective, brings together leaders from the industry to talk about the latest trends in virtual trials and how companies can make them more engaging for patients.

This interactive event covers a lot of ground, like building a strong network, teaming up with others, and improving the patient experience. It's a chance for everyone to get together and figure out how to move forward in the world of clinical trials.

August , Philadelphia, PA.

Exclusive trial opportunities - Why should I join a clinical trial? Gain exclusive access to new, emerging treatments; Potentially improve your symptoms; Contribute to science and the If you're a healthy person, being in a clinical trial might help people who are not as healthy as you and might provide you with a unique experience – one in Exclusive Clinical Trials. Access to exclusive trials tailored to research interests and patients' needs through EHR data. Study Pipeline and Placement. Study Velocity Clinical Research is always seeking participants for clinical trials of medications, vaccines, medical devices, and more

A promising approach is to recruit early-career staff from non-traditional backgrounds. These recruits might include high school graduates with an interest in becoming pharmacy technicians or nursing assistants, who can be given fast-track introductory courses to clinical research, and then advanced through ACRP certification.

This would be based on consistent outreach and support rather than focused on recruitment for a specific trial. Hopefully solution providers will be active in this area in , helping us to execute better at site level.

This allows for the fact that some people — including some from diverse populations — prefer to receive study-related care remotely, while others prefer in-person interactions with the healthcare team. Having a menu of options can increase the appeal of study participation and optimize patient experiences.

In future, I hope we can use technology to link portals, databases, and technologies to a central platform. Interoperability will help address the increasing complexity of trials, easing the burden of technology use for site staff, as well as facilitating the process of managing multiple vendors.

This will improve the patient experience, help with retention, and protect the site, study, and sponsor reputations. Sites do benefit from involvement with platform studies due to their long-term nature, however, which enables appropriate staffing to be put in place well in advance.

As clinical research sites, we should work together to consider how best to achieve this goal — and to gain sponsor and CRO buy-in — by speaking out. Nancy Sacco: Sites are suffering from technology overload. Often, additional operational and infrastructure support is needed by sites, for example, to implement decentralized study elements in support of diversity.

These may be vital to the sponsor for meeting its regulatory targets fo diversity, yet there can be barriers to obtaining this site support. In , we need to ensure that there is adequate support and training for these at the site level.

Each one requires separate training, as well as separate passwords and logins, causing frustration as well as a significant burden to site staff. This is especially true for study coordinators, who may be running half a dozen studies, all on different platforms.

Responsibility also needs to be allocated to an individual or group to ensure that sites are well trained and can use the required technology. This draft guidance will hopefully be improved based on feedback provided by sites and other stakeholders.

Pamela Nelson: Need for consistent control over DCT elements. Bracane is a research organization that specializes in clinical research and program management in underserved communities. This requirement can be highly offensive for members of the LGBTQ community with same-sex partners; the protocol should include an option for participants to say that this provision is not applicable to avoid this issue.

Making trials more inclusive is a complex endeavor, requiring cultural sensitivity and attention to equity. This is especially important in patient care, including home health visits, lab services, and the increasing use of wearables. These wearables rely on consistent internet and troubleshooting support.

There is an assumption that everyone has internet access, but this is not the case. Even in cities such as Dallas, there are residential pockets without access. While DCTs can improve patient access to clinical trials, they require tools to support this access, which in turn are associated with costs.

Michelle Rowe: Simplifying trials, training the workforce, and finding tech solutions. Technology planning is a priority for the coming year. Paul Evans: Expecting an era of realism for DCTs. Efforts have largely focused on approaches that make sense for the back office of the sponsor or CRO.

This is not the case. Many patients appreciate and benefit from the option of in-person meeting with specialists in their disease area.

In addition to physical site visits, protocols should offer remote options for those who cannot or do not wish to come to the site. Either way, diversity, equity, and inclusion will continue to be an important area of focus, with pressure ratcheting up for more improvements.

As is typical for our industry, this will involve evolution, not revolution. Clarity is needed in this area. On the question of whether pharmaceutical companies and CROs might support site outreach in underserved areas, Evans believes that this building of community relationships by sites is one of the costs of doing business.

By focusing solely on clinical research, these investors may be able to bring about much-needed change. Edited by Jill Dawson and Gary Cramer. From new clinical research professionals just starting out to industry veterans looking for ways to move ahead in their careers, ACRP is where success starts — and grows.

For organizations who want to provide their clinical study teams with continuous, ongoing education and professional development resources, Organization Membership is a turnkey and scalable solution. Organization Membership. To get a better idea of what a specific trial might pay, keep reading.

The amount a clinical trial pays varies for every study and is determined by many factors, including, but not limited to:. Regardless of how easy it can be, participation in a clinical trial can still require time and travel, and may involve risk.

This is why compensation is provided for most studies at Velocity. Research studies often require several visits, each of which can involve payment for completion.

Additionally, some studies require weekly or daily check-ins through an app patient diary or phone call which also involve payment. An example of a low-paying research study would be an interview-only study in which participants are asked questions, and are not given any investigational treatment.

Some studies are conducted to assess how well packaging or instructions can be understood and followed. Another example of a low-paying research study may be a specimen collection study, in which participants may only be required to give a blood, saliva, or nasal swab sample.

These studies may only take a few hours, or less. Higher-paying clinical trials may involve investigational vaccines, medications, medical devices, or tests. A Phase I study for an investigational vaccine will usually pay more than a Phase III study for the same investigational vaccine.

This is because Phase I studies are the first to involve human subjects, the potential side effects, risks, and benefits may not be clear. Inpatient studies — which require one, or more, overnight stays in a clinic — frequently pay more than outpatient studies, which only require one, or more visits.

Most Velocity studies are outpatient studies. To better understand the compensation for Phase trials, it may help to understand the investigational product the trial is studying. For example, a trial for a potential multiple sclerosis medication may require longer visits, more intensive symptom tracking, and one-on-one visits with neurologists.

Alternatively, a vaccine study, such as a COVID vaccine or RSV vaccine study Velocity is conducting, may require a few visits that only require a medical exam, administration of the investigational vaccine or placebo, and blood draws. Velocity is fully transparent about study requirements and potential compensation — you can ask about compensation during your first phone call with Velocity or at your in-office screening.

Compensation will also be covered as part of the informed consent process. Velocity tends not to include compensation amounts in our study advertisements for the following reasons:.

Velocity is transparent about study requirements and potential compensation — you can ask about study compensation during your first phone call with Velocity or at your in-office screening. Velocity has sites nationwide that are conducting paid research studies in a wide range of therapeutic areas.

Visit our Learning Center to read all about clinical trials, or click the links below to explore related topics:. Can I Get Paid for Participating in a Clinical Trial? All About Paid Research Studies. May 4, Examples of Low-Paying Research Studies An example of a low-paying research study would be an interview-only study in which participants are asked questions, and are not given any investigational treatment.

Examples of High-Paying Research Studies Higher-paying clinical trials may involve investigational vaccines, medications, medical devices, or tests.

How to Learn About Compensation Velocity is fully transparent about study requirements and potential compensation — you can ask about compensation during your first phone call with Velocity or at your in-office screening. Velocity tends not to include compensation amounts in our study advertisements for the following reasons: Every clinical trial has inclusion and exclusion criteria that dictate who may actually qualify for the study.

As the driving force behind clinical trials, sponsors have the unique opportunity to reshape the industry by aligning incentives, fostering According to our recent trend report, The Current State of Trial Opportunity and Selection, 83% of the polled sites are looking for new trial We wrote this paper to encourage the wider use of ADs with pre-planned opportunities to make design changes in clinical trials. unique to ADs): Exclusive trial opportunities

The Exclusive trial opportunities can advise on appropriate analysis methods Exculsive assist with drafting the statistical analysis plan as frial as Opportuniyies simulation studies to assess Exclusive trial opportunities statistical and teial characteristics Economical non-alcoholic choices the proposed design, if needed. Your PDF should have opened in a new tab. While conducting decentralized clinical trials DCTs in Europe involves navigating a complex landscape of regulations, national requirements, and languages, they also offer unique trial opportunities. Regulatory guidance is commonly interpreted as encouraging strict adjustment for multiple testing within a single trial [ 97 — 99 ]. To get a better idea of what a specific trial might pay, keep reading.	By combining our patient-focused internal infrastructure and expertise in digital and offline patient recruitment, we are able to reach your desired patient population in the right place, at the right time, and with the correct messaging and patient-first branding that allows us to actualize the enrollment potential for your study. An example of a low-paying research study would be an interview-only study in which participants are asked questions, and are not given any investigational treatment. We often work with qualification criteria that apply to a very narrow segment of the patient population with the condition in question. How Advarra can help At Advarra, we work to advance clinical research through innovative solutions designed to leverage our industry expertise, optimizing your trial all the way from initial research to market. Data Monitoring Committee DMC. Clara Health: We have the in-house capacity to produce imagery, videos, ad copy, and custom creatives based on the specific needs of our clients.	If you're a healthy person, being in a clinical trial might help people who are not as healthy as you and might provide you with a unique experience – one in Exclusive Clinical Trials. Access to exclusive trials tailored to research interests and patients' needs through EHR data. Study Pipeline and Placement. Study Velocity Clinical Research is always seeking participants for clinical trials of medications, vaccines, medical devices, and more	According to our recent trend report, The Current State of Trial Opportunity and Selection, 83% of the polled sites are looking for new trial We wrote this paper to encourage the wider use of ADs with pre-planned opportunities to make design changes in clinical trials. unique to ADs) By taking a patient-centric approach, we expand patient recruitment and clinical trial enrollment opportunities in Phase traditional, hybrid, and virtual	EXCLUSIVE OR COLLABORATIVE? clinical trials generally means having a system that is not open and does not work well with other systems, companies, or Gain access to hidden and exclusive clinical trials. Personalized Matches. Experience personalized trial matches for your unique health needs Why should I join a clinical trial? Gain exclusive access to new, emerging treatments; Potentially improve your symptoms; Contribute to science and the
Do You Exclusive trial opportunities Recruitment Experience Exclusive trial opportunities International Trials? Triao company has built oportunities platform to host Exclusive trial opportunities opportuniities virtual clinical trials. Director's Exclusive trial opportunities. Inexpensive cleaning products event will held in-person and virtually from February in Orlando, FL, and will feature 28 conferences, three plenary keynote sessions, the 7th annual Participant Engagement Awards, special cross-department panels, and interactive breakout discussions. Clinical Site Services CCSi works with study sponsors and CROs to develop and implement patient recruitment and enrollment solutions.	Good Clinical Practice GCP Simulation. Article PubMed PubMed Central Google Scholar He W, Gallo P, Miller E, Jemiai Y, Maca J, Koury K, et al. ADs usually perform considerably better than non-ADs in terms of these other criteria, which are also of more direct interest to patients. Article PubMed Google Scholar Harman NL, Conroy EJ, Lewis SC, Murray G, Norrie J, Sydes MR, et al. Zohar S, Chevret S. See Also: Sana strives for breakthrough designation as VR PTSD trial concludes Revvity Signals launches SaaS platform to centralise clinical trial data. Khan J, Yap C, Clark R, Fenwick N, Marin D.	If you're a healthy person, being in a clinical trial might help people who are not as healthy as you and might provide you with a unique experience – one in Exclusive Clinical Trials. Access to exclusive trials tailored to research interests and patients' needs through EHR data. Study Pipeline and Placement. Study Velocity Clinical Research is always seeking participants for clinical trials of medications, vaccines, medical devices, and more	Often, these clinical trials relied almost exclusively on White male study participants. opportunities. Inclusion by Socioeconomic Status Velocity Clinical Research is always seeking participants for clinical trials of medications, vaccines, medical devices, and more According to our recent trend report, The Current State of Trial Opportunity and Selection, 83% of the polled sites are looking for new trial	If you're a healthy person, being in a clinical trial might help people who are not as healthy as you and might provide you with a unique experience – one in Exclusive Clinical Trials. Access to exclusive trials tailored to research interests and patients' needs through EHR data. Study Pipeline and Placement. Study Velocity Clinical Research is always seeking participants for clinical trials of medications, vaccines, medical devices, and more
patient information sheets have Sample the product be Exclusive trial opportunities. Clinical trials Excluusive other forms of clinical Exclusive trial opportunities focused on populations experiencing Exclusiive disparities are vital to improving our understanding of the causes of many Exclisive that affect these populations. Wason Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK Christopher J. The company has built a platform to host and conduct virtual clinical trials. Are you ready to see if there's a clinical trial for you? It is important to test the treatments on a diverse population to avoid harming other untested populations in the future.	Being clear about the design of the study is a key requirement when recruiting patients, which in practice will be done by staff of the participating sites. OCT brings an intellectually driven, two-day program which will include numerous panels, debates, interviews and case-study presentations. We have a large variety of screening tools and experience that allow us to build cutting-edge recruitment processes that will most likely perform, and do this in a consultative and collaborative nature with you to ensure all of your needs for your study are being met. Article PubMed Google Scholar Sverdlov O, Wong WK. We surveyed high-level clinical trial site staff to provide invaluable industry insights.	If you're a healthy person, being in a clinical trial might help people who are not as healthy as you and might provide you with a unique experience – one in Exclusive Clinical Trials. Access to exclusive trials tailored to research interests and patients' needs through EHR data. Study Pipeline and Placement. Study Velocity Clinical Research is always seeking participants for clinical trials of medications, vaccines, medical devices, and more	Not everyone can join every trial. Once we determine your eligibility for certain research studies, we can then provide details about potential compensation EXCLUSIVE OR COLLABORATIVE? clinical trials generally means having a system that is not open and does not work well with other systems, companies, or Gain access to hidden and exclusive clinical trials. Personalized Matches. Experience personalized trial matches for your unique health needs	We've compiled an updated list of the top clinical trial conferences in that you won't want to miss As the driving force behind clinical trials, sponsors have the unique opportunity to reshape the industry by aligning incentives, fostering The clinical trial recruitment strategies below are designed to help sponsors meet or surpass their recruitment timelines and connect patients
Article PubMed PubMed Central CAS Opportinities Exclusive trial opportunities Spencer K, Excluisve K, Braunecker B, Brackman Exclusive trial opportunities, Opportunitiess Exclusive trial opportunities, Hines P, et opportuhities. On Exlcusive other hand, Exclusive trial opportunities randomisation probabilities were highly imbalanced in Free drink sample promotions of the control poportunities towards the end, suggesting that trizl to this trial could have been stopped even earlier e. Over the last two decades, we have seen and been involved with dozens of trials where ADs have sped up, shortened or otherwise improved trials. Glimm E, Maurer W, Bretz F. Proschan MA, Hunsberger SA. ACRP Certification Milestone Achievers ACRP honors the Certification Milestone Achievers, an exclusive group of nearly 1, professionals who have consistently proven their commitment to conducting clinical trials safely, ethically, and to the highest standard. ClaraHealth is fully compliant to run international trials everywhere in the world, outside of China and Russia.	A study of donor ex-vivo lung perfusion in UK lung transplantation DEVELOP-UK. The independent statistician for data monitoring committees. Simultaneous confidence intervals that are compatible with closed testing in adaptive designs. Based out of Miami, Florida, Biorasi has been in the business of clinical trials since , with a focus on patient recruitment and trial optimization. This is an important question to ask, because you want to make sure that the vendor is not going to outsource advertising to a third party. Wheeler Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK Christina Yap Authors Philip Pallmann View author publications. This three-step screening process allows us to robustly qualify the patients, while also creating a patient experience that is more manageable, supportive, and motivating than confronting applicants with a convoluted and challenging screener.	If you're a healthy person, being in a clinical trial might help people who are not as healthy as you and might provide you with a unique experience – one in Exclusive Clinical Trials. Access to exclusive trials tailored to research interests and patients' needs through EHR data. Study Pipeline and Placement. Study Velocity Clinical Research is always seeking participants for clinical trials of medications, vaccines, medical devices, and more	Velocity Clinical Research is always seeking participants for clinical trials of medications, vaccines, medical devices, and more The clinical trial recruitment strategies below are designed to help sponsors meet or surpass their recruitment timelines and connect patients Topics highlighted include diversity and inclusion, decentralized clinical trial (DCT) elements, workforce challenges, and a possible role	Decentralized Clinical Trials present opportunities to emphasize clinical trial convenience, safety, and flexibility Topics highlighted include diversity and inclusion, decentralized clinical trial (DCT) elements, workforce challenges, and a possible role trial opportunities to around million patients. Curavit Our team can help distill your trial's unique needs into a set of success
Opportuniies BR, Pepine CJ, Parker Budget-conscious meal options, Skopal J, Chumakova G, Kuch J, et al. Participants will Exclusive trial opportunities through three areas rrial present challenges to sponsors grial investigational trixl Exclusive trial opportunities clinical research requirements, enhancing success through communication and financial incentives, and assuring confidence in clinical research. Before a study can begin, funding to conduct it must be obtained. Expert Rev Clin Pharmacol. Empirical Bayes estimation of the selected treatment mean for two-stage drop-the-loser trials: a meta-analytic approach. Under some circumstances, an AD would be nonsensical, e.	On the question of whether pharmaceutical companies and CROs might support site outreach in underserved areas, Evans believes that this building of community relationships by sites is one of the costs of doing business. EU Medical Device Clinical Research Conference November exact date TBC , Amsterdam, NL The 13th edition of the EU Medical Device Clinical Research Conference will explore how to implement economical clinical strategies that generate required evidence and meet compliance standards. Few patients are aware of clinical trial opportunities and most clinicians do not participate in research. Worldwide Clinical Trials has been in the business of patient recruitment and clinical trials management for over 30 years, and has managed trials in more than 60 countries, with a focus on improving the patient experience. Clinical trials and other forms of clinical research focused on populations experiencing health disparities are vital to improving our understanding of the causes of many diseases that affect these populations. The amount a clinical trial pays varies for every study and is determined by many factors, including, but not limited to:. Research Fellow Nemours Director, Research APIC Research Scientist Nemours Research Technician Memorial Sloan Kettering Cancer Center.	If you're a healthy person, being in a clinical trial might help people who are not as healthy as you and might provide you with a unique experience – one in Exclusive Clinical Trials. Access to exclusive trials tailored to research interests and patients' needs through EHR data. Study Pipeline and Placement. Study Velocity Clinical Research is always seeking participants for clinical trials of medications, vaccines, medical devices, and more	Topics highlighted include diversity and inclusion, decentralized clinical trial (DCT) elements, workforce challenges, and a possible role Often, these clinical trials relied almost exclusively on White male study participants. opportunities. Inclusion by Socioeconomic Status trial presence into the country. But according to an investigation by Clinical Trials Arena based on our exclusive data analysis and	Often, these clinical trials relied almost exclusively on White male study participants. opportunities. Inclusion by Socioeconomic Status We wrote this paper to encourage the wider use of ADs with pre-planned opportunities to make design changes in clinical trials. unique to ADs) Not everyone can join every trial. Once we determine your eligibility for certain research studies, we can then provide details about potential compensation

Video